# Massachusetts General Hospital: Observational study in End Stage Renal Disease (ESRD), Volume Overload (400 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Massachusetts General Hospital |
| Sponsor type | Academic and hospital |
| Study | Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission |
| NCT ID | NCT07866872 |
| Phase | Observational |
| Status | enrolling by invitation |
| Conditions | End Stage Renal Disease (ESRD); Volume Overload |
| Intervention types | device |
| Target enrollment | 400 |
| Site countries | United States |
| Posted | 2026-10-08 |
| Planned start | 2026-06-17 |
| Event | Newly registered study |
| Event date | 2026-10-08 |

## Why this score
- 400 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07866872). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.